About 11 Trademarks found that are owned by Emergent BIosolutions Canada Inc.
Filters
Mark
Details
Status
Class/Description
CANGENECORPORATION
EMERGENT BIOSOLUTIONS CANADA INC.
85081058
09 Jul 2010
Dead/Cancelled
on 03 Sep 2021
Monoclonal and Polyclonal Antibody Based Pharmaceutical Products from ...
Class 005
Class 005
Pharmaceutical Products
Monoclonal and Polyclonal Antibody Based Pharmaceutical Products from Human and Animal Sources for Use in Treating Infectious Diseases, Blood Disorders and Immunological Diseases; and Recombinant Protein Based Pharmaceutical Products for Treating Hormone Deficiency, Radiation Exposure and Oncology Related Diseases
Dead/Cancelled
on 03 Sep 2021
CANGENECORPORATION
EMERGENT BIOSOLUTIONS CANADA INC.
85081058 · 09 Jul 2010
005
Class 005
Pharmaceutical Products
Monoclonal and Polyclonal Antibody Based Pharmaceutical Products from Human and Animal Sources for Use in Treating Infectious Diseases, Blood Disorders and Immunological Diseases; and Recombinant Protein Based Pharmaceutical Products for Treating Hormone Deficiency, Radiation Exposure and Oncology Related Diseases
Monoclonal and Polyclonal Antibody Based Pharmaceutical Products from ...